Same Indication

Ipilimumab vs Phenytoin

Ipilimumab vs Phenytoin: Overview

This comparison examines the pharmacological differences between Ipilimumab and Phenytoin.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Phenytoin: Sodium channel blocker stabilizing inactive state.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Phenytoin — 22 hours.

Chemical Properties

Molecular Formula: Phenytoin — C15H12N2O2.

Molecular Weight: Phenytoin — 252.2680 g/mol.

Type: Ipilimumab — Antibody; Phenytoin — Small molecule.